Welcome to our dedicated page for Nature’S Sun SEC filings (Ticker: NATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nature’s Sunshine Products, Inc. filings document the public-company record for a Nasdaq-listed Utah corporation that manufactures and markets herbal and nutritional supplements and personal care products. Form 8-K reports furnish operating and financial results, non-GAAP reconciliations, material-event disclosures, executive appointments, compensatory arrangements, material agreements and capital-structure updates for NATR common stock.
Proxy materials cover board elections, governance practices, executive compensation, equity awards, pay-versus-performance disclosure and shareholder voting matters. The filing record also addresses risk, regulatory and business disclosures related to the company’s global wellness product operations and distribution markets.
Herbert Kevin R. reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC executive Kevin R. Herbert, EVP & President, North America, received an equity grant of 8,326 Common Shares in the form of restricted stock units. The grant is recorded at $0.00 per share, indicating a compensation award rather than a market purchase.
Each RSU represents one share of NATR common stock and will vest in three equal annual installments through May 15, 2029. After this award, Herbert directly holds 50,866 Common Shares, showing his total reported equity position, including this new grant.
Straus Robert D reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC director Robert D. Straus received an equity grant of 4,500 common-share RSUs. The award was made at no cash cost per share and will vest on the earlier of one year from the grant date or the company’s annual shareholder meeting. Following this grant, Straus directly holds 56,514 common shares.
Yang Rong reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC director Rong Yang received an equity award of 4,500 restricted stock units. Each RSU represents the right to receive one common share. The RSUs vest on the earlier of one year from the grant date, May 15, 2027, or the company’s next annual shareholder meeting. Following this grant, Yang is reported as holding 34,749 common shares directly.
Kopf Curtis reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC director Curtis Kopf received a grant of 4,500 restricted stock units (RSUs) on common shares as equity compensation. Each RSU represents one share of NATR common stock and will vest on the earlier of one year from the grant date, May 15, 2027, or the company’s annual shareholder meeting. After this award, Kopf holds 34,427 common shares directly.
Roering Tess reported acquisition or exercise transactions in this Form 4 filing.
Nature's Sunshine Products Inc. director Tess Roering received a grant of 4,500 common-share RSUs on May 15, 2026 as equity compensation, with no cash purchase price. Each restricted stock unit represents the right to receive one share of NATR common stock.
The RSUs vest on the earlier of May 15, 2027 or the occurrence of the company’s annual shareholder meeting. Following this award, Roering directly holds 34,427 common shares, including the granted RSUs.
Nature’s Sunshine Products, Inc. reported that Chief Financial Officer L. Shane Jones has resigned effective June 5, 2026, and stated that his decision was not due to any disagreement over the company’s financial reporting or accounting practices. On May 8, 2026, the company appointed longtime finance executive Jonathan D. Lanoy as Interim Principal Financial Officer. Lanoy currently serves as Senior Vice President, Chief Accounting Officer, and Principal Accounting Officer and has been with the company’s finance organization since 2008. Under an existing employment agreement, he receives an annual base salary of $301,551, a target annual bonus equal to 50 percent of base salary, and may receive 12 months of salary and health coverage continuation if his employment ends under specified conditions.
Natures Sunshine Products EVP and General Counsel Nathan G. Brower reported compensation-related share activity tied to performance milestones. On May 5, 2026, performance-based restricted stock units vested in three tranches totaling 5,775 common shares after the company achieved adjusted EBITDA milestones of $51.1M and $52M over rolling 12‑month periods. To cover tax obligations on these vestings, the company withheld a total of 1,668 common shares at a price of $25.915 per share, a tax-withholding disposition rather than an open‑market sale. After these transactions, Brower directly holds 44,359 common shares of Natures Sunshine Products.
NATURES SUNSHINE PRODUCTS INC executive Fritz Erich A reported routine equity compensation activity. On May 5, he acquired 1,372 common shares through vesting of performance-based restricted stock units tied to an adjusted EBITDA milestone of $52M over a rolling 12‑month period.
On the same date, 469 shares were withheld to cover tax obligations, based on the closing share price of $25.915. After these transactions, he directly holds 12,132 common shares, reflecting a modest net increase in ownership from this award.
Natures Sunshine Products Global Chief Marketing Officer Kevin Gregory Fuller reported routine equity compensation activity. He exercised awards tied to restricted stock units to acquire 1,677 common shares and had 573 shares withheld to cover taxes.
Following these transactions, Fuller directly holds 23,137 common shares. The vesting was triggered by the company achieving an adjusted EBITDA milestone of $52 million over a rolling 12‑month period under a performance-based restricted stock unit grant.
NATURES SUNSHINE PRODUCTS INC executive Kevin R. Herbert reported routine equity compensation activity. He acquired 1,500 common shares on May 5, 2026 through a derivative exercise related to performance-based restricted stock units tied to an adjusted EBITDA milestone of $52M over a rolling 12-month period.
On the same date, 366 common shares were withheld to cover tax obligations upon vesting, based on the closing price of $25.915 per share. Following these transactions, Herbert directly holds 42,906 common shares, reflecting net additional ownership from the award after tax withholding.